B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8+ T lymphocytes in vivo

Journal of Experimental Medicine

Volumn 194, Issue 9, 2001, Pages 1339-1348

  Liu, Xingluo ^a   Bai, Xue Feng ^a   Wen, Jing ^a   Gao, Jian Xin ^a   Liu, Jinqing ^a   Lu, Ping ^a   Wang, Yin ^a   Zheng, Pan ^a   Liu, Yang ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

B7H; Clonal expansion; Cytotoxic T lymphocytes; Effector function; Tumor immunity

Indexed keywords

B7 ANTIGEN; P1A ANTIGEN; TUMOR ANTIGEN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TRANSGENE; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE EXPRESSION; LIGANDS; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0035159948     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.194.9.1339     Document Type: Article

References (38)

1. Immunology taught by viruses
2. Immunobiology of tissue transplantation: A return to the passenger leukocyte concept
3. Immunogenicity signals 1, 2, 3... and 0
4. Costimulation of T-cell growth
5. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
6. + cells in the generation of killer activity
7. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen
8. Cytotoxic T lymphocytes to an unmutated tumor antigen P1A: Normal development but restrained effector funcfion
9. + T cell adoptive immunotherapy
10. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
11. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
12. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: An important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells
13. A reassessment of the role of B7-1 expression in tumor rejection
14. Expression of B7 co-stimulatory molecules by B16 melanoma results in a natural killer cell-dependent local antitumour response, but induces T-cell-dependent systemic immunity only against B7-expressing tumours
15. Two mechanisms for tumor evasion of preexisting cytotoxic T-cell responses: Lessons from recurrent tumors
16. The threshold for autoimmune T cell killing is influenced by B7-1
17. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
18. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
19. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha
20. T-cell co-stimulation through B7RP-1 and ICOS
21. B7-H3, a costimulatory molecule for T cell activation and IFN-gamma production
22. PD-L2 is a second ligand for PD-I and inhibits T cell activation
23. Cutting edge: Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor
24. Characterization of human inducible costimulator ligand expression and function
25. LICOS, a primordial costimulatory ligand?
26. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
27. A major costimulatory molecule on antigen-presenting cells. CTLA4 ligand A, is distinct from B7
28. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation
29. Determination of lymphocyte division by flow cytometry
30. Multiple lineages of tumors express a common tumor antigen. P1A, but they are not crossprotected
31. Maturation of cytotoxic T lymphocytes against a B7-transfected nonmetastatic tumor: A critical role for costimulation by B7 on both tumor and host antigen-presenting cells
32. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation
33. ICOS co-stimulatory receptor is essential for T-cell activation and function
34. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
35. ICOS is essential for effective T-helper-cell responses
36. ICOS is critical for CD40-mediated antibody class switching
37. Optimal induction of effector but not memory antitumor cytotoxic T lymphocytes involves direct antigen presentation by the tumor cells
38. Local costimulation reinvigorates tumor-specific cytolytic T lymphocytes for experimental therapy in mice with large tumor burdens